Document is current
Any future updates will be listed below
-
Authors
Skarping, Ida https://orcid.org/0000-0002-1265-8649
Förnvik, Daniel
Sartor, Hanna
Heide-Jørgensen, Uffe
Zackrisson, Sophia
Borgquist, Signe
-
Funding
Funding for this research was provided by:
Swedish Breast Cancer Group
the Governmental Funding of Clinical Research within National Health Services
- License Information
-
More Information
Article History
Received: 27 June 2019
Accepted: 20 December 2019
First Online: 30 December 2019
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Regional Ethics Committee in Lund, Sweden (committee’s reference number: 2014/13 and 2016/521). In accordance to decision from the ethics committee, all living patients received a written letter asking for their consent at the time of the study, and patients declining participation were asked to notice the researchers either by phone or email.
: Not applicable.
: SZ and HS have received speakers’ fees and travel support from Siemens Healthcare AG.The other authors declare that they have no competing interest.
